Trial Profile
Can a novel measure of acute bronchodilator responsiveness predict improvement in exercise capacity after four weeks treatment with tiotropium bromide in subjects with chronic obstructive pulmonary disease?
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Dec 2018
Price :
$35
*
At a glance
- Drugs Salbutamol (Primary) ; Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 20 Dec 2018 Status changed from recruiting to completed.
- 05 May 2011 New trial record